224 related articles for article (PubMed ID: 33091367)
1. Modeling the Impact of Delaying the Diagnosis of Non-Small Cell Lung Cancer During COVID-19.
Shipe ME; Haddad DN; Deppen SA; Kozower BD; Grogan EL
Ann Thorac Surg; 2021 Jul; 112(1):248-254. PubMed ID: 33091367
[TBL] [Abstract][Full Text] [Related]
2. Modeling the impact of delaying surgery for early esophageal cancer in the era of COVID-19.
Shipe ME; Baechle JJ; Deppen SA; Gillaspie EA; Grogan EL
Surg Endosc; 2021 Nov; 35(11):6081-6088. PubMed ID: 33140152
[TBL] [Abstract][Full Text] [Related]
3. Estimating the Impact of Extended Delay to Surgery for Stage I Non-small-cell Lung Cancer on Survival.
Mayne NR; Elser HC; Darling AJ; Raman V; Liou DZ; Colson YL; D'Amico TA; Yang CJ
Ann Surg; 2021 May; 273(5):850-857. PubMed ID: 33630435
[TBL] [Abstract][Full Text] [Related]
4. Modeling the Impact of Delaying Bariatric Surgery due to COVID-19: a Decision Analysis.
Shipe ME; Beeghly-Fadiel A; Deppen SA; English W; Grogan EL
Obes Surg; 2021 Mar; 31(3):1387-1391. PubMed ID: 33104988
[TBL] [Abstract][Full Text] [Related]
5. Collateral effects of the coronavirus disease 2019 pandemic on lung cancer diagnosis in Korea.
Park JY; Lee YJ; Kim T; Lee CY; Kim HI; Kim JH; Park S; Hwang YI; Jung KS; Jang SH
BMC Cancer; 2020 Oct; 20(1):1040. PubMed ID: 33121456
[TBL] [Abstract][Full Text] [Related]
6. Considerations for the Surgical Management of Early Stage Lung Cancer During the COVID-19 Pandemic.
Merritt RE; Kneuertz PJ
Clin Lung Cancer; 2021 May; 22(3):156-160. PubMed ID: 32718772
[TBL] [Abstract][Full Text] [Related]
7. Maintaining Surgical Treatment of Non-Small Cell Lung Cancer During the COVID-19 Pandemic in Paris.
Leclère JB; Fournel L; Etienne H; Al Zreibi C; Onorati I; Roussel A; Castier Y; Martinod E; Le Pimpec-Barthes F; Alifano M; Assouad J; Mordant P;
Ann Thorac Surg; 2021 May; 111(5):1682-1688. PubMed ID: 33038341
[TBL] [Abstract][Full Text] [Related]
8. [Surgical treatment of non-small cell lung cancer in the conditions of a new coronavirus infection pandemic (COVID-19)].
Allakhverdyan AS
Khirurgiia (Mosk); 2020; (7):82-85. PubMed ID: 32736468
[TBL] [Abstract][Full Text] [Related]
9. Pulmonary Lobectomy After COVID-19.
Testori A; Perroni G; Voulaz E; Crepaldi A; Alloisio M
Ann Thorac Surg; 2021 Mar; 111(3):e181-e182. PubMed ID: 32987024
[TBL] [Abstract][Full Text] [Related]
10. Safety of patients and providers in lung cancer surgery during the COVID-19 pandemic.
Chang SH; Zervos M; Kent A; Chachoua A; Bizekis C; Pass H; Cerfolio RJ
Eur J Cardiothorac Surg; 2020 Dec; 58(6):1222-1227. PubMed ID: 33150417
[TBL] [Abstract][Full Text] [Related]
11. Surgical management of lung cancer during the COVID-19 pandemic - a narrative review and single-centre report.
Werner RS; Lörtscher A; Kirschner MB; Lauk O; Furrer K; Caviezel C; Schneiter D; Inci I; Hillinger S; Curioni-Fontecedro A; Opitz I
Swiss Med Wkly; 2022 Jan; 152():w30109. PubMed ID: 35147390
[TBL] [Abstract][Full Text] [Related]
12. A Risk Score to Assist Selecting Lobectomy Versus Sublobar Resection for Early Stage Non-Small Cell Lung Cancer.
Gulack BC; Yang CJ; Speicher PJ; Yerokun BA; Tong BC; Onaitis MW; D'Amico TA; Harpole DH; Hartwig MG; Berry MF
Ann Thorac Surg; 2016 Dec; 102(6):1814-1820. PubMed ID: 27592602
[TBL] [Abstract][Full Text] [Related]
13. Safety of lung cancer surgery during COVID-19 in a pandemic epicenter.
Villena-Vargas J; Lutton EM; Mynard N; Nasar A; Voza F; Chow O; Lee B; Harrison S; Stiles BM; Port JL; Altorki NK
J Thorac Cardiovasc Surg; 2022 Aug; 164(2):378-385. PubMed ID: 35459540
[TBL] [Abstract][Full Text] [Related]
14. The impact of the COVID-19 pandemic on lung cancer patients.
Sha Z; Chang K; Mi J; Liang Z; Hu L; Long F; Shi H; Lin Z; Wang X; Pei X
Ann Palliat Med; 2020 Sep; 9(5):3373-3378. PubMed ID: 33065788
[TBL] [Abstract][Full Text] [Related]
15. Pulmonary Resection for Second Lung Cancer After Pneumonectomy: A Population-Based Study.
Ayub A; Rehmani SS; Al-Ayoubi AM; Raad W; Flores RM; Bhora FY
Ann Thorac Surg; 2017 Oct; 104(4):1131-1137. PubMed ID: 28709663
[TBL] [Abstract][Full Text] [Related]
16. Timing of adjuvant radiation therapy and survival outcomes after surgical resection of intracranial non-small cell lung cancer metastases.
Sheppard JP; Prashant GN; Chen CHJ; Peeters S; Lagman C; Ong V; Udawatta M; Duong C; Nguyen T; Romiyo P; Gaonkar B; Yong WH; Kaprealian TB; Tenn S; Lee P; Yang I
Clin Neurol Neurosurg; 2019 Aug; 183():105389. PubMed ID: 31280101
[TBL] [Abstract][Full Text] [Related]
17. Resection of multifocal non-small cell lung cancer when the bronchioloalveolar subtype is involved.
Roberts PF; Straznicka M; Lara PN; Lau DH; Follette DM; Gandara DR; Benfield JR
J Thorac Cardiovasc Surg; 2003 Nov; 126(5):1597-602. PubMed ID: 14666039
[TBL] [Abstract][Full Text] [Related]
18. Smoking status and 30-day mortality in patients undergoing pulmonary resections.
Mediratta N; Poullis M
Asian Cardiovasc Thorac Ann; 2016 Sep; 24(7):663-9. PubMed ID: 27365496
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors in resected satellite-nodule T4 non-small cell lung cancer.
Rao J; Sayeed RA; Tomaszek S; Fischer S; Keshavjee S; Darling GE
Ann Thorac Surg; 2007 Sep; 84(3):934-8; discussion 939. PubMed ID: 17720402
[TBL] [Abstract][Full Text] [Related]
20. [The place of surgery in metastatic non-small cell lung cancer].
Le Pimpec Barthes F; Mordant P; Pricopi C; Foucault C; Dujon A; Riquet M
Rev Mal Respir; 2012 Mar; 29(3):376-83. PubMed ID: 22440301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
